ARUP announces blood test to identify Alzheimer’s pathology
ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of …
ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of …
Zimmer Biomet has completed the previously announced acquisition of Paragon 28 for an enterprise value of approximately $1.2bn. Announced in January, …
Becton, Dickinson and Company (BD) has introduced the HemoSphere Alta platform, a haemodynamic monitoring system incorporating predictive AI-based algorithms to …
The United Arab Emirates Ministry (UAE) of Health and Prevention has approved Biomerica's Fortel Kidney Disease Test for sale. This authorisation …
Leidos has announced a $10m investment to expedite the AI usage in disease detection and management, in a five-year partnership …
The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with …
RadNet company DeepHealth has signed a $103m deal to acquire iCAD, an AI-powered breast cancer screening company based in New …
Surgeons on England’s National Health Service (NHS) will be able to use state-of-the-art robotic systems that will improve the care …
Research estimates that pressure injuries (otherwise known as bedsores) are attributable to approximately 60,000 deaths per year in the US. …
Bruker has announced a significant investment in Germany-based company RECIPE Chemicals + Instruments, which provides mass spectrometry-based diagnostic assay kits. The …
A top nutritionist at the US National Institutes of Health (NIH) has elected to retire from his post, citing “censorship” …
Aditxt subsidiary Pearsanta has secured approval from WCG Clinical’s Institutional Review Board (IRB) to begin a clinical trial of the …
GeneDx has announced its intention to acquire Fabric Genomics, which allows it to advance in the field of genomic medicine …
Abbott has posted strong revenue for its diabetes devices in Q1, despite overall sales for the company narrowly missing Wall …
The US Food and Drug Administration (FDA) has cleared LUMA Vision’s Verafeye catheter-based imaging system. Verafeye is a four-dimensional (4D), ultrasound-based …